NCT00174980View on ClinicalTrials.gov

Study of Oxycyte in Severe Closed Head Injury

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

July 31, 2008

Conditions
Traumatic Brain Injury
Interventions
DRUG

perfluorocarbon emulsion (Oxycyte) infusion

one time dose of 3mL/kg over 15 minutes

Trial Locations (1)

23298

Virginia Commonwealth University Medical Center, Richmond

All Listed Sponsors
collaborator

Virginia Commonwealth University

OTHER

lead

Tenax Therapeutics, Inc.

INDUSTRY

NCT00174980 - Study of Oxycyte in Severe Closed Head Injury | Biotech Hunter | Biotech Hunter